AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Increasing degradation of Hypoxia-Inducible Factors impairs cancer stem cell proliferation
Summary
This technology describes a method for treating ID2 protein-related diseases through increased degradation of Hypoxia-Inducible Factors (HIFs).
Technology Benefits
Mechanism-backed treatment of ID2 protein-related diseasesApplicable to multiple types of hypoxia-related cancersProvides multiple drug targets for increasing degradation of HIFs, reducing risk of resistance
Technology Application
Treatment and prevention of glioblastoma and other cancersTreatment and prevention of other ID2 protein-related diseasesResearch tool for developing additional targeted therapeutics
Detailed Technology Description
None
Country/Region
USA
For more information, please click Here
